Stay updated on Pembrolizumab Skin Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Skin Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now reflects that recruitment has ended and introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment heading styling and records a revision from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T18:46:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.5.5 appears, replacing the prior v3.5.4. This indicates a minor site update or patch rather than changes to the study details or content.
    Difference
    0.1%
    Check dated 2026-06-08T16:18:28.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision tag on the page changed from v3.5.3 to v3.5.4, indicating a small update to the page’s revision history or documentation. This update does not alter the study details or core content.
    Difference
    0.1%
    Check dated 2026-05-18T03:59:48.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page header/footer revision number was updated from v3.5.2 to v3.5.3, indicating a minor site/version refresh rather than a change to the underlying clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-26T08:25:45.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T01:35:25.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0. No adjustments to study details, eligibility criteria, or results are evident.
    Difference
    0.1%
    Check dated 2026-03-21T08:30:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Skin Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.